The NABIDIOLEX brand, founded in 2003 (United Kingdom), from 21 sister brands and 17477 competing brands. NABIDIOLEX is owned by GW PHARMACEUTICALS, listed on the stock exchange of London The International Securities Identification Number (ISIN) of GW PHARMACEUTICALS is GB0030544687. NABIDIOLEX belongs to the Drug Manufacturers business sector.